ICD-10-CM Billable Code

M1A.49

Other secondary chronic gout, multiple sites

Clinical Classification Guidelines

Medical Intelligence & Overview

Other secondary chronic gout at multiple sites is a long-term form of gout that affects various parts of the body. Gout is a type of arthritis caused by the buildup of uric acid crystals in the joints, leading to pain, swelling, and discomfort. When this condition becomes chronic and involves multiple areas, it indicates ongoing inflammation and damage due to persistent elevated uric acid levels, often influenced by other health conditions or medications.

Causes & Symptoms

Clinical Causes: Persistently high levels of uric acid in the blood (hyperuricemia) Use of certain medications such as diuretics, aspirin, or immunosuppressants Chronic kidney disease impairing uric acid excretion Metabolic conditions like obesity, hypertension, or insulin resistance Diet high in purine-rich foods such as red meat, shellfish, or alcohol

Key Symptoms: Persistent joint pain and swelling that may not subside Limited joint mobility in affected areas Chronic tenderness and inflammation over multiple joints Development of tophi (deposits of uric acid crystals) in skin or other tissues Possible skin redness and warmth over affected joints Feeling of fatigue or malaise in some cases

Diagnostic & Treatment

Diagnosis Path: Diagnosis typically involves a combination of clinical evaluation and laboratory tests. Key diagnostic steps include: - Blood tests measuring serum uric acid levels - Joint fluid analysis to identify uric acid crystals - Imaging studies like X-rays or ultrasound to detect joint damage or tophi - Reviewing medical history, medications, and dietary habits It is crucial for healthcare providers to differentiate gout from other types of arthritis to ensure appropriate management.

Treatment Protocols: Managing other secondary chronic gout with multiple sites involves a multifaceted approach: - Medications to lower uric acid levels, such as xanthine oxidase inhibitors (e.g., allopurinol, febuxostat) - Anti-inflammatory drugs during flare-ups to reduce pain and swelling - Lifestyle and dietary modifications, including avoiding purine-rich foods, reducing alcohol intake, and maintaining a healthy weight - Maintaining adequate hydration to facilitate uric acid excretion - Regular monitoring of uric acid levels to adjust treatment plans - Managing underlying conditions like kidney disease, hypertension, or metabolic syndrome Treatment plans should be tailored to individual needs, emphasizing long-term management to prevent flare-ups and joint damage.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is M1A.49 a billable ICD-10 code?
Yes, M1A.49 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report M1A.49?
Clinical documentation must specify the nature of Other secondary chronic gout, multiple sites and any associated comorbidities for accurate reporting.

Cite this Clinical Reference